Skip to main content
SpringerLink
Log in

The rise and fall of anandamide: processes that control synthesis, degradation, and storage

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Anandamide is an endocannabinoid derived from arachidonic acid-containing membrane lipids and has numerous biological functions. Its effects are primarily mediated by the cannabinoid receptors CB1 and CB2, and the vanilloid TRPV1 receptor. Anandamide is known to be involved in sleeping and eating patterns as well as pleasure enhancement and pain relief. This manuscript provides a review of anandamide synthesis, degradation, and storage and hence the homeostasis of the anandamide signaling system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949. https://doi.org/10.1126/science

    Article  CAS  PubMed  Google Scholar 

  2. Maccarrone M (2017) Metabolism of the endocannabinoid anandamide: open questions after 25 years. Front Mol Neurosci 10:166. https://doi.org/10.3389/fnmol.2017.00166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Marsicano G, Chaouloff F (2011) Moving bliss: a new anandamide transporter. Nat Neurosci 15:5–6. https://doi.org/10.1038/nn.3011

    Article  CAS  PubMed  Google Scholar 

  4. Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21–47. https://doi.org/10.1146/annurev-psych-113011-143739

    Article  PubMed  Google Scholar 

  5. Ross RA (2003) Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 140:790–801. https://doi.org/10.1038/sj.bjp.0705467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mardian EB, Bradley RM, Duncan RE (2015) The HRASLS (PLA/AT) subfamily of enzymes. J Biomed Sci 22:99. https://doi.org/10.1186/s12929-015-0210-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hussain Z, Uyama T, Kawai K, Rahman IA, Tsuboi K, Araki N, Ueda N (2016) Comparative analyses of isoforms of the calcium-independent phosphatidylethanolamine N-acyltransferase PLAAT-1 in humans and mice. J Lipid Res 57:2051–2060. https://doi.org/10.1194/jlr.M071290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D (2016) The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform 54(1):1–30. https://doi.org/10.1002/cpbi.5

    Article  Google Scholar 

  9. Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, Jang W, Katz K, Ovetsky M, Riley G, Sethi A, Tully R, Villamarin-Salomon R, Rubinstein W, Maglott DR (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862-868. https://doi.org/10.1093/nar/gkv1222

    Article  CAS  PubMed  Google Scholar 

  10. Käll L, Krogh A, Sonnhammer EL (2007) Advantages of combined transmembrane topology and signal peptide prediction–the phobius web server. Nucleic Acids Res 35:W429–W432. https://doi.org/10.1093/nar/gkm256

    Article  PubMed  PubMed Central  Google Scholar 

  11. Shinohara N, Uyama T, Jin XH, Tsuboi K, Tonai T, Houchi H, Ueda N (2011) Enzymological analysis of the tumor suppressor A-C1 reveals a novel group of phospholipid-metabolizing enzymes. J Lipid Res 52:1927–1935. https://doi.org/10.1194/jlr.M015081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Uyama T, Tsuboi K, Ueda N (2017) An involvement of phospholipase A/acyltransferase family proteins in peroxisome regulation and plasmalogen metabolism. FEBS Lett 591:2745–2760. https://doi.org/10.1002/1873-3468.12787

    Article  CAS  PubMed  Google Scholar 

  13. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pontén F (2015) Tissue-based map of the human proteome. Science 347:1260419. https://doi.org/10.1126/science

    Article  PubMed  Google Scholar 

  14. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296–W303. https://doi.org/10.1093/nar/gky427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Blom N, Sicheritz-Pontén T, Gupta R, Gammeltoft S, Brunak S (2004) Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4:1633–1649. https://doi.org/10.1002/pmic.200300771

    Article  CAS  PubMed  Google Scholar 

  16. Steentoft C, Vakhrushev SY, Joshi HJ, Kong Y, Vester-Christensen MB, Schjoldager KT, Lavrsen K, Dabelsteen S, Pedersen NB, Marcos-Silva L, Gupta R, Bennett EP, Mandel U, Brunak S, Wandall HH, Levery SB, Clausen H (2013) Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32:1478–1488. https://doi.org/10.1038/emboj.2013.79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351–1362. https://doi.org/10.1006/jmbi.1999.3310

    Article  CAS  PubMed  Google Scholar 

  18. Uyama T, Ikematsu N, Inoue M, Shinohara N, Jin XH, Tsuboi K, Tonai T, Tokumura A, Ueda N (2012) Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family. J Biol Chem 287:31905–31919. https://doi.org/10.1074/jbc.M112.368712

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schäfer R (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol 136:935–944. https://doi.org/10.1083/jcb.136.4.935

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Golczak M, Kiser PD, Sears AE, Lodowski DT, Blaner WS, Palczewski K (2012) Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins. J Biol Chem 287:23790–23807. https://doi.org/10.1074/jbc.M112.361550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Uyama T, Jin XH, Tsuboi K, Tonai T, Ueda N (2009) Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Biochim Biophys Acta 1791:1114–1124. https://doi.org/10.1016/j.bbalip.2009.07.001

    Article  CAS  PubMed  Google Scholar 

  22. Magotti P, Bauer I, Igarashi M, Babagoli M, Marotta R, Piomelli D, Garau G (2015) Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids. Structure 23:598–604. https://doi.org/10.1016/j.str.2014.12.018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Uyama T, Morishita J, Jin XH, Okamoto Y, Tsuboi K, Ueda N (2009) The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J Lipid Res 50:685–693. https://doi.org/10.1194/jlr.M800453-JLR200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pang XY, Cao J, Addington L, Lovell S, Battaile KP, Zhang N, Rao JL, Dennis EA, Moise AR (2012) Structure/function relationships of adipose phospholipase A2 containing a cys-his-his catalytic triad. J Biol Chem 287:35260–35274. https://doi.org/10.1074/jbc.M112.398859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS (2008) Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). J Biol Chem 283:25428–32546. https://doi.org/10.1074/jbc.M804146200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Higuchi E, Chandraratna RA, Hong WK, Lotan R (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22:4627–4635. https://doi.org/10.1038/sj.onc.1206235

    Article  CAS  PubMed  Google Scholar 

  27. Jin XH, Uyama T, Wang J, Okamoto Y, Tonai T, Ueda N (2009) cDNA cloning and characterization of human and mouse Ca(2+)-independent phosphatidylethanolamine N-acyltransferases. Biochim Biophys Acta 1791:32–38. https://doi.org/10.1016/j.bbalip.2008.09.006

    Article  CAS  PubMed  Google Scholar 

  28. Hussain Z, Uyama T, Kawai K, Binte Mustafiz SS, Tsuboi K, Araki N, Ueda N (2018) Phosphatidylserine-stimulated production of N-acyl-phosphatidylethanolamines by Ca2+-dependent N-acyltransferase. Biochim Biophys Acta Mol Cell Biol Lipids 1863:493–502. https://doi.org/10.1016/j.bbalip.2018.02.002

    Article  CAS  PubMed  Google Scholar 

  29. Binte Mustafiz SS, Uyama T, Hussain Z, Kawai K, Tsuboi K, Araki N, Ueda N (2019) The role of intracellular anionic phospholipids in the production of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2e. J Biochem 165:343–352. https://doi.org/10.1093/jb/mvy104

    Article  CAS  PubMed  Google Scholar 

  30. Ogura Y, Parsons WH, Kamat SS, Cravatt BF (2016) A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines. Nat Chem Biol 12:669–671. https://doi.org/10.1038/nchembio.2127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Murray D, Honig B (2002) Electrostatic control of the membrane targeting of C2 domains. Mol Cell 9:145–154. https://doi.org/10.1016/s1097-2765(01)00426-9

    Article  CAS  PubMed  Google Scholar 

  32. Hussain Z, Uyama T, Tsuboi K, Ueda N (2017) Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines. Biochim Biophys Acta Mol Cell Biol Lipids 1862:1546–1561. https://doi.org/10.1016/j.bbalip.2017.08.006

    Article  CAS  PubMed  Google Scholar 

  33. Capestrano M, Mariggio S, Perinetti G, Egorova AV, Iacobacci S, Santoro M, Di Pentima A, Iurisci C, Egorov MV, Di Tullio G, Buccione R, Luini A, Polishchuk RS (2014) Cytosolic phospholipase A2e drives recycling through the clathrin-independent endocytic route. J Cell Sci 127:977–993. https://doi.org/10.1242/jcs.136598

    Article  CAS  PubMed  Google Scholar 

  34. Liu J, Wang L, Harvey-White J, Huang BX, Kim HY, Luquet S, Palmiter RD, Krystal G, Rai R, Mahadevan A, Razdan RK, Kunos G (2008) Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54:1–7. https://doi.org/10.1016/j.neuropharm.2007.05.020

    Article  CAS  PubMed  Google Scholar 

  35. Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R (2012) N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci USA 109:12449–12454. https://doi.org/10.1073/pnas.1210303109

    Article  PubMed  PubMed Central  Google Scholar 

  36. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298–5305. https://doi.org/10.1074/jbc.M306642200

    Article  CAS  PubMed  Google Scholar 

  37. Wang J, Okamoto Y, Morishita J, Tsuboi K, Miyatake A, Ueda N (2006) Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. J Biol Chem 281:12325–12335. https://doi.org/10.1074/jbc.M512359200

    Article  CAS  PubMed  Google Scholar 

  38. Margheritis E, Castellani B, Magotti P, Peruzzi S, Romeo E, Natali F, Mostarda S, Gioiello A, Piomelli D, Garau G (2016) Bile acid recognition by NAPE-PLD. ACS Chem Biol 11:2908–2914. https://doi.org/10.1021/acschembio.6b00624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Lefort C, Roumain M, Van Hul M, Rastelli M, Manco R, Leclercq I, Delzenne NM, Marzo VD, Flamand N, Luquet S, Silvestri C, Muccioli GG, Cani PD (2020) Hepatic NAPE-PLD Is a key regulator of liver lipid metabolism. Cells 9(1247):1. https://doi.org/10.3390/cells9051247

    Article  CAS  Google Scholar 

  40. Simon GM, Cravatt BF (2006) Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281:26465–26472. https://doi.org/10.1074/jbc.M604660200

    Article  CAS  PubMed  Google Scholar 

  41. Ohshima N, Kudo T, Yamashita Y, Mariggiò S, Araki M, Honda A, Nagano T, Isaji C, Kato N, Corda D, Izumi T, Yanaka N (2014) New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity. J Biol Chem 290:4260–4271. https://doi.org/10.1074/jbc.M114.614537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Rahman IA, Tsuboi K, Hussain Z, Yamashita R, Okamoto Y, Uyama T, Yamazaki N, Tanaka T, Tokumura A, Ueda N (2016) Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7. Biochim Biophys Acta 1861:1881–1892. https://doi.org/10.1016/j.bbalip.2016.09.008

    Article  CAS  PubMed  Google Scholar 

  43. Zheng B, Berrie CP, Corda D, Farquhar MG (2003) GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors. Proc Natl Acad Sci USA 100:1745–1750. https://doi.org/10.1073/pnas.0337605100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Tsuboi K, Okamoto Y, Rahman IA, Uyama T, Inoue T, Tokumura A, Ueda N (2015) Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis. Biochim Biophys Acta 1851:537–548. https://doi.org/10.1016/j.bbalip.2015.01.002

    Article  CAS  PubMed  Google Scholar 

  45. Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang BX, Kim HY, Kunos G (2006) A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103:13345–13350. https://doi.org/10.1073/pnas.0601832103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ayakannu T, Taylor AH, Bari M, Mastrangelo N, Maccarrone M, Konje JC (2019) Expression and function of the endocannabinoid modulating enzymes fatty acid amide hydrolase and N-Acylphosphatidylethanolamine-specific phospholipase D in endometrial carcinoma. Front Oncol 9:1363. https://doi.org/10.3389/fonc.2019.01363

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lundby A, Secher A, Lage K, Nordsborg NB, Dmytriyev A, Lundby C, Olsen JV (2012) Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun 3:876. https://doi.org/10.1038/ncomms1871

    Article  CAS  PubMed  Google Scholar 

  48. Sun YX, Tsuboi K, Okamoto Y, Tonai T, Murakami M, Kudo I, Ueda N (2004) Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase. Biochem J 380:749–756. https://doi.org/10.1042/BJ20040031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Szymczak-Pajor I, Kleniewska P, Wieczfinska J, Pawliczak R (2020) Wide-range effects of 1,25(OH)2D3 on group 4A phospholipases is related to nuclear factor k-B and phospholipase-A2 activating protein activity in mast cells. Int Arch Allergy Immunol 181:56–70. https://doi.org/10.1159/000503628

    Article  CAS  PubMed  Google Scholar 

  50. Chang PA, Shao HB, Long DX, Sun Q, Wu YJ (2008) Isolation, characterization and molecular 3D model of human GDE4, a novel membrane protein containing glycerophosphodiester phosphodiesterase domain. Mol Membr Biol 25:557–566. https://doi.org/10.1080/09687680802537605

    Article  CAS  PubMed  Google Scholar 

  51. Bachmann AS, Duennebier FF, Mocz G (2006) Genomic organization, characterization, and molecular 3D model of GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase. Gene 371:144–153. https://doi.org/10.1016/j.gene.2005.11.023

    Article  CAS  PubMed  Google Scholar 

  52. Zheng B, Chen D, Farquhar MG (2000) MIR16, a putative membrane glycerophosphodiester phosphodiesterase, interacts with RGS16. Proc Natl Acad Sci USA 97:3999–4004. https://doi.org/10.1073/pnas.97.8.3999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Aoyama C, Horibata Y, Ando H, Mitsuhashi S, Arai M, Sugimoto H (2019) Characterization of glycerophosphodiesterase 4-interacting molecules Gaq/11 and Gb, which mediate cellular lysophospholipase D activity. Biochem J 476:3721–3736. https://doi.org/10.1042/BCJ20190666

    Article  CAS  PubMed  Google Scholar 

  54. Aoyama C, Sugimoto H, Ando H, Yamashita S, Horibata Y, Sugimoto S, Satou M (2011) The heterotrimeric G protein subunits Ga(q) and Gb(1) have lysophospholipase D activity. Biochem J 440:241–250. https://doi.org/10.1042/BJ20110545

    Article  CAS  PubMed  Google Scholar 

  55. Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, Tang J, Jeffery D, Mortara K, Sampang J, Williams SR, Buggy J, Clark JM (2006) Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem 281:11002–11010. https://doi.org/10.1074/jbc.M600498200

    Article  CAS  PubMed  Google Scholar 

  56. Tsai SJ, Sen U, Zhao L, Greenleaf WB, Dasgupta J, Fiorillo E, Orrú V, Bottini N, Chen XS (2009) Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation. Biochemistry 48:4838–4845. https://doi.org/10.1021/bi900166y

    Article  CAS  PubMed  Google Scholar 

  57. Barr AJ, Ugochukwu E, Lee WH, King ON, Filippakopoulos P, Alfano I, Savitsky P, Burgess-Brown NA, Müller S, Knapp S (2009) Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136:352–363. https://doi.org/10.1016/j.cell.2008.11.038

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Yang S, Svensson MND, Harder NHO, Hsieh WC, Santelli E, Kiosses WB, Moresco JJ, Yates JR 3rd, King CC, Liu L, Stanford SM, Bottini N (2020) PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling. Sci Signal 13:eaaw8130. https://doi.org/10.1126/scisignal.aaw8130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12:260–271. https://doi.org/10.1021/pr300630k

    Article  CAS  PubMed  Google Scholar 

  60. Yu X, Sun JP, He Y, Guo X, Liu S, Zhou B, Hudmon A, Zhang ZY (2007) Structure, inhibitor, and regulatory mechanism of lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci USA 104:19767–19772. https://doi.org/10.1073/pnas.0706233104

    Article  PubMed  PubMed Central  Google Scholar 

  61. An H, Xu H, Zhang M, Zhou J, Feng T, Qian C, Qi R (2005) Cao X (2005) Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. Blood 105:4685–4692. https://doi.org/10.1182/blood-2005-01-0191

    Article  CAS  PubMed  Google Scholar 

  62. Lamkin TD, Walk SF, Liu L, Damen JE, Krystal G, Ravichandran KS (1997) Shc interaction with src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J Biol Chem 272:10396–10401. https://doi.org/10.1074/jbc.272.16.10396

    Article  CAS  PubMed  Google Scholar 

  63. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143:1174–1189. https://doi.org/10.1016/j.cell.2010.12.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Cao L, Yu K, Banh C, Nguyen V, Ritz A, Raphael BJ, Kawakami Y, Kawakami T, Salomon AR (2007) Quantitative time-resolved phosphoproteomic analysis of mast cell signaling. J Immunol 179:5864–5876. https://doi.org/10.4049/jimmunol.179.9.5864

    Article  CAS  PubMed  Google Scholar 

  65. Chiang KP, Gerber AL, Sipe JC, Cravatt BF (2004) Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 13:2113–2119. https://doi.org/10.1093/hmg/ddh216

    Article  CAS  PubMed  Google Scholar 

  66. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281:36569–36578. https://doi.org/10.1074/jbc.M606646200

    Article  CAS  PubMed  Google Scholar 

  67. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83–87. https://doi.org/10.1038/384083a0

    Article  CAS  PubMed  Google Scholar 

  68. Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94:2238–2242. https://doi.org/10.1073/pnas.94.6.2238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agrò A, Rossi A (2003) Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278:32726–32732. https://doi.org/10.1074/jbc.M302123200

    Article  CAS  PubMed  Google Scholar 

  70. Dainese E, De Fabritiis G, Sabatucci A, Oddi S, Angelucci CB, Di Pancrazio C, Giorgino T, Stanley N, Del Carlo M, Cravatt BF, Maccarrone M (2014) Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH. Biochem J 457:463–472. https://doi.org/10.1042/BJ20130960

    Article  CAS  PubMed  Google Scholar 

  71. Sirrs S, van Karnebeek CD, Peng X, Shyr C, Tarailo-Graovac M, Mandal R, Testa D, Dubin D, Carbonetti G, Glynn SE, Sayson B, Robinson WP, Han B, Wishart D, Ross CJ, Wasserman WW, Hurwitz TA, Sinclair G, Kaczocha M (2015) Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms. Orphanet J Rare Dis 10:38. https://doi.org/10.1186/s13023-015-0248-3

    Article  PubMed  PubMed Central  Google Scholar 

  72. Kaczocha M, Glaser ST, Chae J, Brown DA, Deutsch DG (2010) Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. J Biol Chem 285:2796–2806. https://doi.org/10.1074/jbc.M109.058461

    Article  CAS  PubMed  Google Scholar 

  73. Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T, Ueda N (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280:11082–11092. https://doi.org/10.1074/jbc.M413473200

    Article  CAS  PubMed  Google Scholar 

  74. West JM, Zvonok N, Whitten KM, Wood JT, Makriyannis A (2012) Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase. J Proteome Res 11:972–981. https://doi.org/10.1021/pr200735a

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Zhao LY, Tsuboi K, Okamoto Y, Nagahata S, Ueda N (2007) Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism. Biochim Biophys Acta 1771:1397–1405. https://doi.org/10.1016/j.bbalip.2007.10.002

    Article  CAS  PubMed  Google Scholar 

  76. Yu M, Ives D, Ramesha CS (1997) Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272:21181–21186. https://doi.org/10.1074/jbc.272.34.21181

    Article  CAS  PubMed  Google Scholar 

  77. Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF (2008) The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther 327:538–545. https://doi.org/10.1124/jpet.108.141796

    Article  CAS  PubMed  Google Scholar 

  78. Walker VJ, Griffin AP, Hammar DK, Hollenberg PF (2016) Metabolism of anandamide by human cytochrome P450 2J2 in the reconstituted system and human intestinal microsomes. J Pharmacol Exp Ther 357:537–544. https://doi.org/10.1124/jpet.116.232553

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Snider NT, Kornilov AM, Kent UM, Hollenberg PF (2007) Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol Exp Ther 321:590–597. https://doi.org/10.1124/jpet.107.119321

    Article  CAS  PubMed  Google Scholar 

  80. Sridar C, Snider NT, Hollenberg PF (2011) Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. Drug Metab Dispos 39:782–788. https://doi.org/10.1124/dmd.110.036707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Hampson AJ, Hill WA, Zan-Phillips M, Makriyannis A, Leung E, Eglen RM, Bornheim LM (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta 1259:173–179. https://doi.org/10.1016/0005-2760(95)00157-8

    Article  PubMed  Google Scholar 

  82. Sakura Y, Tsuboi K, Uyama T, Zhang X, Taoka R, Sugimoto M, Kakehi Y, Ueda N (2016) A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells. Biochim Biophys Acta 1861:1951–1958. https://doi.org/10.1016/j.bbalip.2016.09.018

    Article  CAS  PubMed  Google Scholar 

  83. Gorelik A, Gebai A, Illes K, Piomelli D, Nagar B (2018) Molecular mechanism of activation of the immunoregulatory amidase NAAA. Proc Natl Acad Sci USA 115:E10032–E10040. https://doi.org/10.1073/pnas.1811759115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Wang J, Zhao LY, Uyama T, Tsuboi K, Tonai T, Ueda N (2008) Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase. Biochim Biophys Acta 1781:710–717. https://doi.org/10.1016/j.bbalip.2008.08.004

    Article  CAS  PubMed  Google Scholar 

  85. Tai T, Tsuboi K, Uyama T, Masuda K, Cravatt BF, Houchi H, Ueda N (2012) Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA). ACS Chem Neurosci 3:379–385. https://doi.org/10.1021/cn300007s

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Pavlopoulos S, Pelekoudas DN, Benchama O, Rawlins CM, Agar JN, West JM, Malamas M, Zvonok N, Makriyannis A (2018) Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies. Protein Exp Purif 145:108–117. https://doi.org/10.1016/j.pep.2017.12.005

    Article  CAS  Google Scholar 

  87. Biringer RG (2020) The enzymology of the human prostanoid pathway. Mol Biol Rep 47:4569–4586. https://doi.org/10.1007/s11033-020-05526-z

    Article  CAS  PubMed  Google Scholar 

  88. Boutaud O, Montine TJ, Chang L, Klein WL, Oates JA (2006) PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. J Neurochem 96:917–923. https://doi.org/10.1111/j.1471-4159.2005.03586.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Salomon RG, Miller DB, Zagorski MG, Coughlin DJ (1984) Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J Am Chem Soc 106:6049–6060

    Article  CAS  Google Scholar 

  90. Urquhart P, Wang J, Woodward DF, Nicolaou A (2015) Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea. J Lipid Res 56:1419–1433. https://doi.org/10.1194/jlr.M055772

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Woodward DF, Liang Y, Krauss AH (2008) Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol 153:410–419. https://doi.org/10.1038/sj.bjp.0707434

    Article  CAS  PubMed  Google Scholar 

  92. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277:44877–44885. https://doi.org/10.1074/jbc.M206788200

    Article  CAS  PubMed  Google Scholar 

  93. Woodward DF, Wang JW, Poloso NJ (2013) Recent progress in prostaglandin F2a ethanolamide (prostamide F2a) research and therapeutics. Pharmacol Rev 65:1135–1147. https://doi.org/10.1124/pr.112.007088

    Article  CAS  PubMed  Google Scholar 

  94. Nemeth JF, Hochgesang GP Jr, Marnett LJ, Caprioli RM (2001) Characterization of the glycosylation sites in cyclooxygenase-2 using mass spectrometry. Biochemistry 40:3109–3116. https://doi.org/10.1021/bi002313c

    Article  CAS  PubMed  Google Scholar 

  95. Alexanian A, Miller B, Chesnik M, Mirza S, Sorokin A (2014) Post-translational regulation of COX2 activity by FYN in prostate cancer cells. Oncotarget 5:4232–4243. https://doi.org/10.18632/oncotarget.1983

    Article  PubMed  PubMed Central  Google Scholar 

  96. Kim SF, Huri DA, Snyder SH (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966–1970. https://doi.org/10.1126/science.1119407

    Article  CAS  PubMed  Google Scholar 

  97. Cuendet M, Mesecar AD, DeWitt DL, Pezzuto JM (2006) An ELISA method to measure inhibition of the COX enzymes. Nat Protoc 1:1915–1921. https://doi.org/10.1038/nprot.2006.308

    Article  CAS  PubMed  Google Scholar 

  98. Ristimäki A, Garfinkel S, Wessendorf J, Maciag T, Hla T (1994) Induction of cyclooxygenase-2 by Interleukin-la. Evidence for post-transcriptional regulation. J Biol Chem 269:11769–11775

    Article  PubMed  Google Scholar 

  99. Parfenova H, Balabanova L, Leffler CW (1998) Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells. Am J Physiol 274:C72–C81. https://doi.org/10.1152/ajpcell.1998.274.1.C72

    Article  CAS  PubMed  Google Scholar 

  100. Akerman S, Romero-Reyes M, Holland PR (2017) Current and novel insights into the neurophysiology of migraine and its implications for therapeutics. Pharmacol Ther 172:151–170. https://doi.org/10.1016/j.pharmthera.2016.12.005

    Article  CAS  PubMed  Google Scholar 

  101. Snider NT, Nast JA, Tesmer LA, Hollenberg PF (2009) A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. Mol Pharmacol 75:965–972. https://doi.org/10.1124/mol.108.053439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Kozak KR, Marnett LJ (2002) Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66:211–220. https://doi.org/10.1054/plef.2001.0359

    Article  CAS  PubMed  Google Scholar 

  103. Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol Pharmacol 54:180–188. https://doi.org/10.1124/mol.54.1.180

    Article  CAS  PubMed  Google Scholar 

  104. Biringer RG (2018) The Enzymes of the human eicosanoid pathway. Res Rep Med Sci 2:106

    Google Scholar 

  105. van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone M (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45:3709–3720. https://doi.org/10.1021/jm020818q

    Article  CAS  PubMed  Google Scholar 

  106. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL (2011) Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 50:115–131. https://doi.org/10.1016/j.plipres.2010.10.005

    Article  CAS  PubMed  Google Scholar 

  107. Natarajan R, Rosdahl J, Gonzales N, Bai W (1997) Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension 30:873–879. https://doi.org/10.1161/01.hyp.30.4.873

    Article  CAS  PubMed  Google Scholar 

  108. Forsell PK, Brunnström A, Johannesson M, Claesson HE (2012) Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. Lipids 47:781–791. https://doi.org/10.1007/s11745-012-3684-z

    Article  CAS  PubMed  Google Scholar 

  109. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912–3917. https://doi.org/10.4049/jimmunol.178.6.3912

    Article  CAS  PubMed  Google Scholar 

  110. Chen X, Zhang J, Chen C (2011) Endocannabinoid 2-arachidonoylglycerol protects neurons against a-amyloid insults. Neuroscience 178:159–168. https://doi.org/10.1016/j.neuroscience.2011.01.024

    Article  CAS  PubMed  Google Scholar 

  111. Kuhn H, Gehring T, Schröter A, Heydeck D (2016) Cytokine-dependent expression regulation of ALOX15. J Cytokine Biol 1:106. https://doi.org/10.4172/2576-3881.1000106

    Article  Google Scholar 

  112. Maccarrone M, Dainese E, Oddi S (2010) Intracellular trafficking of anandamide: new concepts for signaling. Trends Biochem Sci 35:601–608. https://doi.org/10.1016/j.tibs.2010.05.008

    Article  CAS  PubMed  Google Scholar 

  113. Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M (2018) Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. Proc Natl Acad Sci USA 115:3482–3487. https://doi.org/10.1073/pnas.1721339115

    Article  PubMed  PubMed Central  Google Scholar 

  114. De Maio A, Vazquez D (2013) Extracellular heat shock proteins: a new location, a new function. Shock 40:239–246. https://doi.org/10.1097/SHK.0b013e3182a185ab

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Kaczocha M, Lin Q, Nelson LD, McKinney MK, Cravatt BF, London E, Deutsch DG (2012) Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion. ACS Chem Neurosci 3:364–368. https://doi.org/10.1021/cn300001w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manček-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-’t Hoen EN, Nyman TA, O’Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066. https://doi.org/10.3402/jev.v4.27066

    Article  PubMed  Google Scholar 

  117. Gabrielli M, Battista N, Riganti L, Prada I, Antonucci F, Cantone L, Matteoli M, Maccarrone M, Verderio C (2015) Active endocannabinoids are secreted on extracellular membrane vesicles. EMBO Rep 16:213–220. https://doi.org/10.15252/embr.201439668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Bojesen IN, Hansen HS (2005) Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 46:1652–1659. https://doi.org/10.1194/jlr.M400498-JLR200

    Article  CAS  PubMed  Google Scholar 

  119. Fowler CJ (2013) Transport of endocannabinoids across the plasma membrane and within the cell. FEBS J 280:1895–1904. https://doi.org/10.1111/febs.12212

    Article  CAS  PubMed  Google Scholar 

  120. Di Pasquale E, Chahinian H, Sanchez P, Fantini J (2009) The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent. PLoS ONE 4(3):e4989. https://doi.org/10.1371/journal.pone.0004989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG (2012) Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem 287:3415–34124. https://doi.org/10.1074/jbc.M111.304907

    Article  CAS  PubMed  Google Scholar 

  122. Chicca A, Marazzi J, Nicolussi S, Gertsch J (2012) Evidence for bidirectional endocannabinoid transport across cell membranes. J Biol Chem 287:34660–34682. https://doi.org/10.1074/jbc.M112.373241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. McFarland MJ, Porter AC, Rakhshan FR, Rawat DS, Gibbs RA, Barker EL (2004) A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J Biol Chem 279:41991–41997. https://doi.org/10.1074/jbc.M407250200

    Article  CAS  PubMed  Google Scholar 

  124. Oddi S, Fezza F, Pasquariello N, De Simone C, Rapino C, Dainese E, Finazzi-Agrò A, Maccarrone M (2008) Evidence for the intracellular accumulation of anandamide in adiposomes. Cell Mol Life Sci 65:840–850. https://doi.org/10.1007/s00018-008-7494-7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA

    Roger Gregory Biringer

Authors
  1. Roger Gregory Biringer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger Gregory Biringer.

Ethics declarations

Conflict of interest

The author states that he has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file2 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biringer, R.G. The rise and fall of anandamide: processes that control synthesis, degradation, and storage. Mol Cell Biochem 476, 2753–2775 (2021). https://doi.org/10.1007/s11010-021-04121-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-021-04121-5

Keywords

Search

Navigation